CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Novarad Corp. v. Medivis, Inc.

1:21-cv-01447

Overview

Case Number 1:21-cv-01447
Filing Date 2021-10-13
Status Litigation filed
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:1 Patent Infringement
Jury Demand Plaintiff

Parties

Defendant

Medivis, Inc. Operating Company

Represented By

4 Attorneys Listed

John S. Curran

Email: jcurran@mccarter.com

Erik Paul Belt

Email: ebelt@mccarter.com

Alexandra M. Joyce

McCarter & English, LLP

Tel: +1 (302) 984-6392
Fax: +1 (302) 450-4235

Renaissance Centre, 405 N. King Street, 8th Floor

Brian R. Lemon

McCarter & English, LLP

Tel: +1 (302) 984-6300

Renaissance Centre, 405 N. King Street, 8th Floor

Plaintiff

Novarad Corp. Operating Company

Represented By

6 Attorneys Listed

Thatcher A. Rahmeier

Faegre Drinker Biddle & Reath LLP

Tel: +1 (302) 467-4211
Fax: +1 (302) 467-4201

222 Delaware Avenue, Suite 1410

Peter M. de Jonge

Email: dejonge@tnw.com

Mark Bettilyon

Email: mark.bettilyon@tnw.com

Jed H. Hansen

Email: hansen@tnw.com

Brett J. Davis

Email: Brett.Davis@tnw.com

Francis DiGiovanni

Faegre Drinker Biddle & Reath LLP

Tel: +1 (302) 467-4266
Fax: +1 (302) 467-4201

222 Delaware Avenue, Suite 1410

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 4 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts Counterparts in force
πŸ›οΈ
USPTO PTAB Trials 2 proceedings
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (4): πŸ‡ΊπŸ‡Έ US 🌐 PCT
Parallel Proceedings Across Jurisdictions (2 found):
PTAB: 2
USPTO PTAB Trial 2022-10-12
IPR2023-00045

Medivis, Inc. v. Novarad Corp.

Asserted Patent
Status: Final Written Decision
USPTO PTAB Trial 2022-10-12
IPR2023-00042

Medivis, Inc. v. Novarad Corp.

U.S. Continuation Sibling (11004271)
Status: Final Written Decision
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

2 Patents

There are 2 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US10945807
Augmented reality viewing and tagging for medical procedures
Filed: 2018-02-21
Issued: 2021-03-16
Active (11.3 yrs remaining)
Expires: 2038-02-21
US11004271
Augmenting real-time views of a patient with three-dimensional data
Filed: 2019-09-18
Issued: 2021-05-11
Active (12.8 yrs remaining)
Expires: 2039-09-18

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Active Threat

Active Threat β€” Patent is within enforceable statutory term. Patentee retains legal standing to seek permanent injunctive relief and exclusion orders.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term β€” No obviousness-type double patenting truncation noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. 4th Year Maintenance Fee Paid (8th Year Window Upcoming).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

24

Dispositive

15

Granted

0

Denied

1

Pending / Review

20

Motions by Category

Motion to Dismiss (FRCP 12(b)(6)) 6 Motion to Dismiss 4 Claim Construction / Markman Filing 6 Procedural / Extension Motion 1 Motion to Stay Pending IPR / Reexam 4 Motion to Stay 2 Motion to Dismiss (35 U.S.C. Β§ 101 / Alice) 1

Key Dispositive Motions & Rulings

Motion to Dismiss (FRCP 12(b)(6)) Denied
ORAL ORDER: IT IS HEREBY ORDERED that Medivis's Motion to Stay Pending Completion of Inter Partes Reviews (D.I. 51) is denied as moot in light of the parties' s...
Entry #64 • 2023-09-21 Document →
Motion to Dismiss Pending / Under Review
ORAL ORDER: By no later than December 1, 2022, the parties shall submit to the Court two (2) courtesy copies of the briefs related to Defendant's Motion to Dism...
Entry #59 • 2022-11-29 Document →
Motion to Stay Pending IPR / Reexam Pending / Under Review
REPLY BRIEF re 51 MOTION to Stay Pending Completion of Inter Partes Reviews filed by Medivis, Inc.. (Attachments: # 1 Exhibit 7-9)(Lemon, Brian) (Entered: 11/29...
Entry #60 • 2022-11-29 Document →
Motion to Dismiss (35 U.S.C. Β§ 101 / Alice) Pending / Under Review
ORAL ORDER: For purposes of analyzing the motion to dismiss based on invalidity pursuant to 35 U.S.C. Β§ 101, IT IS HEREBY ORDERED that, no later than November 3...
Entry #58 • 2022-11-17 Document →
Motion to Stay Pending IPR / Reexam Pending / Under Review
ANSWERING BRIEF in Opposition re 51 MOTION to Stay Pending Completion of Inter Partes Reviews filed by Novarad Corp..Reply Brief due date per Local Rules is 11/...
Entry #57 • 2022-11-15 Document →
Motion to Dismiss Pending / Under Review
ORAL ORDER: IT IS HEREBY ORDERED that the Court will hear oral argument on Defendant's Motion to Dismiss (D.I. 11) on December 13, 2022, beginning at 10:00 a.m....
Entry #54 • 2022-10-28 Document →

Docket Entries

(114 total)
Pleading / Complaint

COMPLAINT filed with Jury Demand against Medivis, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3719767.) - filed by Novarad Corp.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Civil Cover Sheet)(apk) (Entered: 10/13/2021)

Entry #1 • 2021-10-13
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (apk) (Entered: 10/13/2021)

Entry #2 • 2021-10-13
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,945,807 ;11,004,271. (apk) (Entered: 10/13/2021)

Entry #3 • 2021-10-13
1

Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Novarad Corp.. (apk) (Entered: 10/13/2021)

Entry #4 • 2021-10-13
1

Summons Issued with Magistrate Consent Notice attached as to Medivis, Inc. on 10/13/2021. (apk) (Entered: 10/13/2021)

Entry #5 • 2021-10-13
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc